Pathway | Gene symbol2 | FDR | Log2FC | Gene-ID |
---|
Fatty acid synthesis |
FASN
| < 0.001 | 1.375 | 24,950 |
ACACA
| < 0.001 | 1.011 | 23,708 |
ACSBG2
| 0.037 | 1.683 | 9568 |
Linoleic acid metabolism |
PLA2G2D1
| < 0.001 | 2.239 | 2731 |
CYP3A24
| < 0.001 | 4.498 | 30,249 |
CYP2E1
| < 0.001 | 13.169 | 30,981 |
HRAS-3
| < 0.001 | 14.152 | 32,537 |
PPAR signalling pathway |
UCP1
| < 0.001 | 3.011 | 21,041 |
ACSBG2
| 0.037 | 1.683 | 9568 |
APO-A1
| < 0.001 | −1.230 | 18,573 |
OLR1
| 0.009 | −1.145 | 7294 |
APO-C3
| 0.002 | −1.003 | 18,572 |
SLC27A2
| 0.047 | −11.379 | 13,784 |
ANGPTL4
| < 0.001 | −1.228 | 9509 |
- 1Results based on RNA sequencing, n = 6. The gene expressions were considered to be significantly altered when fold change ≥ 2 and FDR < 0.05
- 2FASN Fatty acid synthetase, ACACA Acetyl-CoA carboxylase, ACSBG2 Long-chain-fatty-acid–CoA ligase ACSBG2 isoform X1, CYP3A24 Cytochrome P450 3A24, CYP2E1 Cytochrome P450 2E1, HRAS-3 HRAS-like suppressor 3, PLA2G2D1 Calcium-dependent phospholipase A2 PLA2G2D1 precursor, UCP1 Mitochondrial brown fat uncoupling protein 1, APO-A1 Apolipoprotein A-I preproprotein, OLR1 Oxidized low-density lipoprotein receptor 1, APO-C3 Apolipoprotein C-III precursor, SLC27A2 Very long-chain acyl-CoA synthetase, ANGPTL4 Angiopoietin-related protein 4 precursor